Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Same As
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
Requires public institutions and buildings to be equipped with opioid antagonists; directs the commissioner of general services to promulgate regulations to address the appropriate number of opioid antagonists for such buildings based on the size or occupancy of the buildings, the training of personnel and use of opioid antagonists, and any other matter deemed necessary.
Requires public institutions and buildings to be equipped with opioid antagonists; directs the commissioner of general services to promulgate regulations to address the appropriate number of opioid antagonists for such buildings based on the size or occupancy of the buildings, the training of personnel and use of opioid antagonists, and any other matter deemed necessary.